In particular, the KRAS rs8720 and NRAS rs14804 SNPs play an important role in these patients, especially where certain genotypes are associated with a higher risk of disease progression and more aggressive clinical features, including lymph node spread and advanced cancer stages. This evidence concerns the gene NRAS and cancer.